Niall O'donnell - Net Worth and Insider Trading
Niall O'donnell Net Worth
The estimated net worth of Niall O'donnell is at least $46 Million dollars as of 2024-06-05. Niall O'donnell is the Director of Mirum Pharmaceuticals Inc and owns about 1,621,118 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $42 Million. Niall O'donnell is the Director of Reneo Pharmaceuticals Inc and owns about 2,188,713 shares of Reneo Pharmaceuticals Inc (RPHM) stock worth over $4 Million. Niall O'donnell is also the Director of Spruce Biosciences Inc and owns about 1,326,305 shares of Spruce Biosciences Inc (SPRB) stock worth over $924,302. Details can be seen in Niall O'donnell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Niall O'donnell has not made any transactions after 2023-05-08 and currently still holds the listed stock(s).
Transaction Summary of Niall O'donnell
Niall O'donnell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Niall O'donnell owns 3 companies in total, including Reneo Pharmaceuticals Inc (RPHM) , Spruce Biosciences Inc (SPRB) , and Mirum Pharmaceuticals Inc (MIRM) .
Click here to see the complete history of Niall O'donnell’s form 4 insider trades.
Insider Ownership Summary of Niall O'donnell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RPHM | Reneo Pharmaceuticals Inc | 2023-05-08 | director |
| SPRB | Spruce Biosciences Inc | 2023-02-16 | director |
| MIRM | Mirum Pharmaceuticals Inc | 2022-11-15 | director |
Niall O'donnell Latest Holdings Summary
Niall O'donnell currently owns a total of 3 stocks. Among these stocks, Niall O'donnell owns 1,621,118 shares of Mirum Pharmaceuticals Inc (MIRM) as of November 15, 2022, with a value of $42 Million and a weighting of 90.17%. Niall O'donnell owns 2,188,713 shares of Reneo Pharmaceuticals Inc (RPHM) as of May 8, 2023, with a value of $4 Million and a weighting of 7.84%. Niall O'donnell also owns 1,326,305 shares of Spruce Biosciences Inc (SPRB) as of February 16, 2023, with a value of $924,302 and a weighting of 1.99%.
Latest Holdings of Niall O'donnell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals Inc | 2022-11-15 | 1,621,118 | 25.79 | 41,808,633 |
| RPHM | Reneo Pharmaceuticals Inc | 2023-05-08 | 2,188,713 | 1.66 | 3,633,264 |
| SPRB | Spruce Biosciences Inc | 2023-02-16 | 1,326,305 | 0.70 | 924,302 |
Holding Weightings of Niall O'donnell
Niall O'donnell Form 4 Trading Tracker
According to the SEC Form 4 filings, Niall O'donnell has made a total of 2 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the sale of 300,000 shares on November 15, 2022, which brought Niall O'donnell around $6 Million.
According to the SEC Form 4 filings, Niall O'donnell has made a total of 2 transactions in Reneo Pharmaceuticals Inc (RPHM) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Reneo Pharmaceuticals Inc is the acquisition of 125,000 shares on May 8, 2023, which cost Niall O'donnell around $1,000,000.
According to the SEC Form 4 filings, Niall O'donnell has made a total of 2 transactions in Spruce Biosciences Inc (SPRB) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Spruce Biosciences Inc is the acquisition of 630,400 shares on February 16, 2023, which cost Niall O'donnell around $2 Million.
Insider Trading History of Niall O'donnell
- 1
Niall O'donnell Trading Performance
GuruFocus tracks the stock performance after each of Niall O'donnell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Niall O'donnell is -15.94%. GuruFocus also compares Niall O'donnell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Niall O'donnell within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Niall O'donnell's insider trading performs compared to the benchmark.
Performance of Niall O'donnell
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.67 | | | | | |
| Relative Return to S&P 500(%) | -3.79 | | | | | |
Niall O'donnell Ownership Network
Niall O'donnell Owned Company Details
What does Reneo Pharmaceuticals Inc do?
Who are the key executives at Reneo Pharmaceuticals Inc?
Niall O'donnell is the director of Reneo Pharmaceuticals Inc. Other key executives at Reneo Pharmaceuticals Inc include Chief Development Officer Ashley Hall , 10 percent owner Novo Holdings A/s , and Senior VP & Corporate Operation Michael Cruse .
Reneo Pharmaceuticals Inc (RPHM) Insider Trades Summary
Over the past 18 months, Niall O'donnell made 1 insider transaction in Reneo Pharmaceuticals Inc (RPHM) with a net purchase of 125,000. Other recent insider transactions involving Reneo Pharmaceuticals Inc (RPHM) include a net purchase of 414,281 shares made by Braden Michael Leonard , a net sale of 100,000 shares made by Novo Holdings A/s , and a net sale of 15,625 shares made by Ashley Hall .
In summary, during the past 3 months, insiders sold 0 shares of Reneo Pharmaceuticals Inc (RPHM) in total and bought 414,281 shares, with a net purchase of 414,281 shares. During the past 18 months, 115,625 shares of Reneo Pharmaceuticals Inc (RPHM) were sold and 539,281 shares were bought by its insiders, resulting in a net purchase of 423,656 shares.
Reneo Pharmaceuticals Inc (RPHM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Reneo Pharmaceuticals Inc Insider Transactions
Niall O'donnell Mailing Address
Above is the net worth, insider trading, and ownership report for Niall O'donnell. You might contact Niall O'donnell via mailing address: C/o Rivervest Venture Partners, 101 South Hanley Rd., Ste 1850, St. Louis Mo 63105.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
